Cargando…

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

Atherosclerosis is an inflammatory vascular disease responsible for the first cause of mortality worldwide. Recent studies have clearly highlighted the critical role of the immunoinflammatory balance in the modulation of disease development and progression. However, the immunoregulatory pathways tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taleb, Soraya, Romain, Mélissa, Ramkhelawon, Bhama, Uyttenhove, Catherine, Pasterkamp, Gerard, Herbin, Olivier, Esposito, Bruno, Perez, Nicolas, Yasukawa, Hideo, Van Snick, Jacques, Yoshimura, Akihiko, Tedgui, Alain, Mallat, Ziad
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2009
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757872/ https://www.ncbi.nlm.nih.gov/pubmed/19737863 http://dx.doi.org/10.1084/jem.20090545

Ejemplares similares

B cell depletion reduces the development of atherosclerosis in mice
por: Ait-Oufella, Hafid, et al.
Publicado: (2010)

Interleukin 5 Contributes to Human Atherosclerosis Development But not to Thrombotic Complications
por: Ait-Oufella, Hafid, et al.
Publicado: (2019)

SOCS, Inflammation, and Autoimmunity
por: Yoshimura, Akihiko, et al.
Publicado: (2012)

IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice
por: Hanada, Toshikatsu, et al.
Publicado: (2006)

Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet
por: Metghalchi, Sarvenaz, et al.
Publicado: (2018)

The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?
por: Mallat, Ziad, et al.
Publicado: (2017)

SOCS3: A novel therapeutic target for cardioprotection
por: Yasukawa, Hideo, et al.
Publicado: (2012)

SOCS, inflammation, and cancer
por: Inagaki-Ohara, Kyoko, et al.
Publicado: (2013)

B Cell–Activating Factor Neutralization Aggravates Atherosclerosis
por: Tsiantoulas, Dimitrios, et al.
Publicado: (2018)

SOCS1 and Regulation of Regulatory T Cells Plasticity
por: Takahashi, Reiko, et al.
Publicado: (2014)

Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-γ and counteraction by interferon-γ
por: Kelchtermans, Hilde, et al.
Publicado: (2009)

Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells
por: Ponnuswamy, Padmapriya, et al.
Publicado: (2017)

IL-33 reduces the development of atherosclerosis
por: Miller, Ashley M., et al.
Publicado: (2008)

The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation
por: Gaignage, Mélanie, et al.
Publicado: (2019)

Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1
por: Kinjyo, Ichiko, et al.
Publicado: (2006)

Spred-2 Suppresses Aorta-Gonad-Mesonephros Hematopoiesis by Inhibiting MAP Kinase Activation
por: Nobuhisa, Ikuo, et al.
Publicado: (2004)

CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis
por: Tupin, Emmanuel, et al.
Publicado: (2004)

Negative regulation of cytokine signaling and immune responses by SOCS proteins
por: Yoshimura, Akihiko, et al.
Publicado: (2005)

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children
por: Galassetti, Pietro R., et al.
Publicado: (2011)

Complementary and Alternative Medicine in Children with Type 1 Diabetes Mellitus
por: Haliloglu, Belma, et al.
Publicado: (2011)

3M Syndrome: A Report of Four Cases in Two Families
por: Güven, Ayla, et al.
Publicado: (2011)

Interleukin 25 promotes the initiation of proallergic type 2 responses
por: Angkasekwinai, Pornpimon, et al.
Publicado: (2007)

Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis
por: Cua, Daniel J., et al.
Publicado: (1999)

Inhibition of Interleukin 7 Receptor Signaling by Antigen Receptor Assembly
por: Smart, Fiona M., et al.
Publicado: (2000)

The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells
por: Moriyama, Maiko, et al.
Publicado: (2005)

Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice
por: Giles, Daniel A., et al.
Publicado: (2016)

Interleukin 2 Signaling Is Required for CD4(+) Regulatory T Cell Function
por: Furtado, Gláucia C., et al.
Publicado: (2002)

Cd47 Ligation Selectively Downregulates Human Interleukin 12 Production
por: Armant, Myriam, et al.
Publicado: (1999)

Role of Macrophage Socs3 in the Pathogenesis of Aortic Dissection
por: Ohno‐Urabe, Satoko, et al.
Publicado: (2018)

Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27
por: Wirtz, Stefan, et al.
Publicado: (2006)

Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells
por: Mohamadzadeh, Mansour, et al.
Publicado: (2001)

T Cell–Independent Interleukin 15rα Signals Are Required for Bystander Proliferation
por: Lodolce, James P., et al.
Publicado: (2001)

C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
por: Jones, Simon A., et al.
Publicado: (1999)

Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes
por: Sozzani, Silvano, et al.
Publicado: (1998)

In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
por: Lachmann, Helen J., et al.
Publicado: (2009)

Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells
por: Moniruzzaman, Md, et al.
Publicado: (2023)

Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation
por: Kawazoe, Yoshinori, et al.
Publicado: (2001)

Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
por: Ait-Oufella, Hafid, et al.
Publicado: (2021)

A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production
por: Matsumoto, Akira, et al.
Publicado: (2003)

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis
por: de Jager, Saskia C.A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rrrm226ftk0i0g29v7vfko58q9